12/1
09:21 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
12/1
09:21 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
12/1
06:04 am
ptct
PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.
Medium
Report
PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.
12/1
06:04 am
ptct
PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.
Medium
Report
PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.
12/1
05:39 am
ptct
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
Medium
Report
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
12/1
05:39 am
ptct
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
Medium
Report
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
11/6
09:59 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/6
09:59 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
03:43 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
03:43 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
12:11 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
12:11 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
11:57 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
11:57 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
11:57 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
10:08 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
10:08 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/5
07:19 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
11/5
07:01 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
10/28
02:53 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/28
02:53 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/20
08:14 am
ptct
PTC Therapeutics (NASDAQ:PTCT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $73.00 price target on the stock.
Medium
Report
PTC Therapeutics (NASDAQ:PTCT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $73.00 price target on the stock.